Profit Breakthrough: Yidu Tech Steals the Show in 2026
Well, who saw this one coming? Yidu Tech (02158.HK), an AI-powered healthcare player, has finally broken into the green with its first full-year profit, hitting a RMB 78.8 million net profit wallop. That's right, they're not just scraping by—they've blasted past their own targets. And that number stands head and shoulders above the already optimistic guidance of RMB 55 million to RMB 70 million they tossed out to investors. Fancy that.
Strong Financial Footing and Broad Growth
Yidu Tech's total revenue jumped 14.6% to hit RMB 820 million for FY2026. Even more impressive is their EBITDA—adjusted to hit RMB 220 million, multiplying more than 4.6 times. You don't see that kind of growth every day. Their gross margin crept up from 33.5% to 36.4%, a clear indication they’re not resting on their laurels.
The silver lining here is their cash flow. They've turned the tide with positive net operating cash flow in the second half, totaling RMB 29.3 million. A testament to their growing financial muscle.
Riding the Wave of AI Advancements
The AI for Medical segment continued to thrive, with new orders surging 22.3%. Meanwhile, over in AI for Life Sciences, orders went through the roof at a 42% increase. It’s good stuff, truly, pointing to what's possibly a very bright horizon for further revenue streams. They're not just playing it safe; they're expanding across the board.
The Clout of YiduCore
The backbone of their success? That's YiduCore—an AI infrastructure that's not just your run-of-the-mill neural network. We're talking about a robust data governance platform, bolstered by real-world medical data processed to the tune of 9 billion records. Their arsenal includes disease models and even a health-focused large language model, all compiled into a seamless operational framework.
With the backdrop of real-world healthcare needs and expectations, YiduCore pretty much makes Yidu Tech a heavy hitter in the healthcare field. Covering over 100 disease areas, its disease repository isn't static, it's dynamic and ever-evolving, further broadening the Company’s competitive edge.
Power Trio: The Business Segments
Yidu Tech's trifecta of business segments aren't sitting idle; they're hard at work redefining AI capabilities. The AI for Medical segment isn’t slouching, clocking in revenue that moved up 10.2% year over year with an impressive network that stretches far and wide.
- AI for Life Sciences: This segment, touching every corner of pharmaceutical chains, grew 9.4% as Yidu Tech catered to industry giants for clinical research and real-world studies.
- AI for Care: The frontrunner in growth, it boasts a 37.6% leap forward in revenue, leveraging deep inroads in health insurance programs and digital therapeutics for chronic conditions like diabetes.
The Road Ahead: Sustainability and Beyond
The buzzword here is sustainability. Yidu Tech isn't just counting the cash; they're also eyeing long-term potential and deeper market penetration. With all this expansion, it sounds like the healthcare AI community isn't just whispering their name—they're shouting it from the rooftops.
As the Company pivots toward sustainable business models by integrating AI into healthcare like never before, their strategic choices and prudent allocation of resources are poised to deliver measurable returns to stakeholders.
With major milestones and ongoing growth, Yidu Tech is aiming to cement itself as the bedrock for healthcare AI systems. If they continue to evolve their offerings with the same gusto and nuanced understanding of real-world applications, these profits may well just be the tip of an even larger iceberg.
